Bi-phasic intensity-dependent opioid-mediated neural amplitude changes in the chinchilla cochlea: Partial blockade by an N-Methyl-d-Aspartate (NMDA)-receptor antagonist

European Journal of Pharmacology

Volumn 580, Issue 1-2, 2008, Pages 100-115

  Sahley, Tony L ^a   Anderson, David J ^a   Chernicky, Cheryl L ^b  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Opioid receptors; (+) MK 801 (dizocilpine hydrogen maleate); ( ) pentazocine; Auditory nerve; Compound action potential; Dynorphins; Glutamate; Lateral efferent olivocochlear system; N Methyl d Aspartate (NMDA) receptors; U 50488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE; PENTAZOCINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ARTICLE; CHINCHILLA LANIGER; COCHLEA; COCHLEA FENESTRA; COCHLEAR NERVE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RODENT; SOUND PRESSURE; STATISTICAL SIGNIFICANCE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ACOUSTIC STIMULATION; ACTION POTENTIALS; ANIMALS; AUDITORY THRESHOLD; CHINCHILLA; COCHLEA; COCHLEAR NERVE; DIZOCILPINE MALEATE; DYNORPHINS; EVOKED POTENTIALS, AUDITORY; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PENTAZOCINE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, KAPPA;

EID: 37649010112     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.038     Document Type: Article

References (120)

1. Abou-Madi L., Pontarotti P., Tramu G., Cupo A., and Eybalin M. Coexistence of putative neuroactive substances in lateral olivocochlear neurons in guinea pig and rat. Hear. Res. 30 (1987) 135-146
2. Altschuler R.A., Reeks K.A., Fex J., and Hoffman D.W. Lateral olivocochlear neurons contain both enkephalin and dynorphin immunoreactivities. J. Histochem. Cytochem. 36 (1988) 797-801
3. Arcaya J.-L., Cano G., Gomez G., Maixner W., and Suarez-Roca H. Dynorphin A increases substance P release from trigeminal primary afferent C-fibers. Eur. J. Pharmacol. 366 (1999) 27-34
4. Azeredo W.J., Kliment M.J., Morley B.J., Relkin E., Slepecky N.B., Sterns A., Warr W.B., Weekly J.M., and Woods C.I. Olivocochlear neurons in the chinchilla: a retrograde fluorescent labelling study. Hear. Res. 134 (1999) 57-70
5. Basbaum A.I., and Jessell T.M. The perception of pain. In: Kandel E.R., Schwartz J.H., and Jessell T.M. (Eds). Principles of Neural Science. fourth ed. (2000), McGraw-Hill, New York, NY 472-491
6. Beauchaine K.A., Kaminski J.R., and Gorga P. Comparison of Beyer DT48 and Etymotic insert earphones: auditory brain stem response measurements. Ear Hear. 8 (1987) 292-297
7. Bobbin R.P., May J.G., and Lemoine R.L. Effects of pentobarbital and ketamine on brain stem auditory potentials. Arch. Otolaryngol. 105 (1979) 467-470
8. Brayton C.F. Dimethyl sulfoxide (DMSO): a review. Cornell Vet. 76 (1986) 61-90
9. + channel blockade and recordings from cochlea and brainstem. Hear. Res. 190 (2004) 60-74
10. Caudle R.M., and Dubner R. Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus. Neuropeptides 32 (1998) 87-95
11. Chen G.-D., Kong J., Reinhard K., and Fechter L.D. NMDA receptor blockage protects against permanent noise-induced hearing loss but not its potentiation by carbon monoxide. Hear. Res. 154 (2001) 108-115
12. Chen L., Gu Y., and Huang L.-Y.M. The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J. Neurosci. 15 (1995) 4602-4611
13. Comis S.D., and Leng G. Action of putative neurotransmitters in the guinea pig cochlea. Exp. Brain Res. 36 (1979) 119-128
14. Crain S.M., and Shen K.-F. GM1 ganglioside-induced modulation of opioid receptor-mediated functions. Ann. N.Y. Acad. Sci. 845 (1998) 106-125
15. d'Aldin C.G., Ruel J., Assié R., Pujol R., and Puel J.L. Implication of NMDA type glutamate receptors in neural regeneration and neoformation of synapses after excitotoxic injury in the guinea pig cochlea. Int. J. Dev. Neurosci. 15 (1997) 619-629
16. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1999) 7-61
17. Dolan D.F., Nuttall A.L., and Avinash G. Asynchronous neural activity recorded from the round window. J. Acoust. Soc. Am. 87 (1990) 2621-2627
18. Drescher D.G., and Drescher M.J. HPLC analysis of presumptive neurotransmitters in perilymph. In: Drescher D.G. (Ed). Auditory Biochemistry (1985), C.C. Thomas, Springfield, Il. 50-67
19. Dubner R., and Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15 (1992) 96-103
20. Ehrenberger K., and Felix D. Glutamate receptors in afferent cochlear neurotransmission in guinea pigs. Hear. Res. 52 (1991) 73-80
21. Ehrenberger K., and Felix D. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey. Acta Otolaryngol. 115 (1995) 236-240
22. Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol. Rev. 73 (1993) 309-373
23. Eybalin M., and Altschuler R.A. Immunoelectron microscopic localization of neurotransmitters in the cochlea. J. Electron Micros. Tech. 15 (1990) 209-224
24. Faden A.I. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J. Neurosci. 12 (1992) 425-429
25. Felix D., and Ehrenberger K. The role of glutamate at the afferent synapses of mammalian inner hair cells: a microiontophoretic study. Inner Ear Biol. 26 (1989) 19
26. Felix D., and Ehrenberger K.A. Microiontophoretic study of the role of excitatory amino acids at the afferent synapses of mammalian inner hair cells. Eur. Arch. Otorhinolaryngol. 248 (1990) 1-3
27. Felix D., and Ehrenberger K. N-Methyl-d-Aspartate-induced oscillations in excitatory afferent neurotransmission in the guinea pig cochlea. Eur. Arch. Otorhinolaryngol. 248 (1991) 429-431
28. George D., and Mallery P. SPSS for Windows (1999), Allyn & Bacon, Needham Heights, MA
29. Goycoolea M.V., and Lundman L. Round window membrane structure function and permeability: a review. Microsc. Res. Tech. 36 (1997) 201-211
30. Goycoolea M.V., Muchow D., and Schachem P.A. Experimental studies on round window membrane structure function and permeability. Laryngoscope 98 (1988) 1-20
31. Groff J.A., and Liberman M.C. Modulation of cochlear afferent responses by the lateral olivocochlear system: activation via electrical stimulation of the inferior colliculus. J. Neurophysiol. 90 (2003) 3178-3200
32. Guinan J.J. Physiology of olivocochlear efferents. In: Dallos P., Popper A.N., and Fay R.R. (Eds). The Cochlea: Springer Handbook of Auditory Research (1996), Springer-Verlag, New York, N.Y. 435-502
33. Gutstein H.B., and Akil A. Opioid analgesics. In: Hardman J.G., and Limbird L.E. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. tenth ed. (2001), McGraw-Hill, New York, N.Y. 569-619
34. Hall J.W. Effect of nonpathologic subject characteristics. Handbook of Auditory Evoked Responses (1992), Allyn & Bacon, Needham Heights, MA 70-103
35. Hall J.W., Mackey-Hargadine J., and Allen S.J. Monitoring neurologic status of comatose patients in the intensive care unit. In: Jacobson J.T. (Ed). The Auditory Brainstem Response (1985), College-Hill Press, San Diego, CA 253-283
36. Hauser K.F., Foldes J.K., and Turbek C.S. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons. Exp. Neurol. 160 (1999) 361-375
37. Hauser K.F., Knapp P.E., and Turbek C.S. Structure-activity analysis of dynorphin-A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin-A and its carboxyl-terminal, nonopioid metabolites. Exp. Neurol. 168 (2001) 78-87
38. Henry K.R. Auditory nerve neurophonic recorded from the round window of the Mongolian gerbil. Hear. Res. 90 (1995) 176-184
39. Hollmann M., and Heinemann S.F. Cloned glutamate receptors. Annu. Rev. Neurosci. 17 (1994) 31-108
40. Jäger W., Goiny M., Herrera-Marschitz M., Flock Å., Hökfelt T., and Brundin L. Sound-evoked efflux of excitatory amino acids in the guinea-pig cochlea in vitro. Exp. Brain Res. 121 (1998) 425-432
41. Jongkamonwiwat N., Phansuwan-Pujito P., Sarapoke P., Chetsawang B., Casalotti S.O., Forge A., Dodson H., and Govitrapong P. The presence of opioid receptors in rat inner ear. Hear. Res. 181 (2003) 85-93
42. Jongkamonwiwat N., Phansuwan-Pujito P., Casalotti S.O., Forge A., Dodson H., and Govitrapong P. The existence of opioid receptors in the cochlea of guinea pigs. Eur. J. Neurosci. 23 (2006) 2701-2711
43. Juhn S.K., Rybak L.P., and Prado S. Nature of blood-labyrinth barrier in experimental conditions. Ann. Otol. 90 (1981) 135-141
44. Juhn S.K., Hamaguchi Y., and Goycoolea M.V. Review of round window membrane permeability. Acta Otolaryngol. Suppl. 457 (1988) 43-48
45. Kandel E.R., and Siegelbaum S.A. Synaptic integration. In: Kandel E.R., Schwartz J.H., and Jessell T.M. (Eds). Principles of Neural Science. fourth ed. (2000), McGraw-Hill, New York, N.Y. 207-228
46. Kleinlogel S., Oestreicher E., Arnold T., Ehrehberger K., and Felix D. Metabotropic glutamate receptors group I are involved in cochlear neurotransmission. Neuroreport 10 (1999) 1879-1882
47. Kuriyama H., Albin R.L., and Altschuler R.A. Expression of NMDA-receptor mRNA in the rat cochlea. Hear. Res. 69 (1993) 215-220
48. 1 DPOAE response to continuous primary stimulation: II. Influence of local calcium-dependent mechanisms. Hear. Res. 97 (1996) 153-164
49. 3H] U-69593, a highly selective ligand for the opioid κ receptor. Eur. J. Pharmacol. 109 (1985) 281-284
50. Lai J., Ossipov M.H., Vanderah T.W., Malan T.P., and Porreca F. Neuropathic pain: the paradox of dynorphin. Pharmacol. Rev. 1 (2001) 160-167
51. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., and Wilcox G.L. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 72 (1997) 253-260
52. Laughlin T.M., Larson A.A., and Wilcox G.L. Mechanisms of induction of persistent nociception by dynorphin. J. Pharmacol. Exp. Ther. 299 (2001) 6-11
53. Le Prell C.G., Bledsoe S.C., Bobbin R.P., and Puel J.-L. Neurotransmission in the inner ear: functional and molecular analyses. In: Jahn A.F., and Santos-Sacchi J. (Eds). Physiology of The Ear. second ed. (2001), Singular-Thomson Learning, San Diego, CA 575-611
54. Le Prell C.G., Shore S.E., Hughes L.F., and Bledsoe S.C. Disruption of lateral efferent pathways: functional changes in auditory evoked responses. J. Assoc. Res. Otolaryngol. 4 (2003) 276-290
55. Le Prell C.G., Halsey K.I., Dolan D.F., and Bledsoe Jr. S.C. Kappa opioid-receptor agonists depress compound action potential amplitude. Abs. Assoc. Res. Otolaryngol. 27 (2004) 329-330
56. Le Prell, C.G., Halsey, K.I., Dolan, D.F., Bledsoe Jr., S.C., submittted for publication. Kappa opioid-receptor agonists have an intensity-dependent biphasic effect on cochlear evoked potential amplitudes.
57. Liberman M.C. Physiology of cochlear efferent and afferent neurons: direct comparisons in the same animal. Hear. Res. 34 (1988) 179-192
58. Liberman M.C. Effects of chronic cochlear de-efferentation on auditory-nerve response. Hear. Res. 49 (1990) 209-224
59. Maison S.F., Adams J.C., and Liberman M.C. Olivocochlear innervations in the mouse: immunocytochemical maps, crossed versus uncrossed contributions, and transmitter colocalization. J. Comp. Neurol. 455 (2003) 406-416
60. Mallory S.B., Lehman P.A., Vanderpool D.R., and Franz T.J. Topical lidocaine for anesthesia in patients undergoing pulsed dye laser treatment for vascular malformations. Pediatr. Dermatol. 10 (1993) 370-375
61. 1 receptor in the rat CNS and pituitary. Neuroscience 71 (1996) 671-690
62. McBain C.J., and Mayer M.L. N-Methyl-d-aspartic acid receptor structure and function. Physiol. Rev. 74 (1994) 723-760
63. McMahon C.M., Brown D.J., and Patuzzi R.B. Transient focal cooling at the round window and cochlear nucleus shows round window CAP originates from cochlear neurones alone. Hear. Res. 190 (2004) 75-86
64. Merchan-Perez A., and Liberman M.C. Ultrastructural differences among afferent synapses on cochlear hair cells: correlations with spontaneous discharge rate. J. Comp. Neurol. 371 (1996) 208-221
65. Miller C.A., Abbas P.J., and Robinson B.K. Characterization of wave I of the electrically evoked auditory brainstem response in the guinea pig. Hear. Res. 69 (1993) 35-44
66. Muchnik C., Sahartov E., Peleg E., and Hildesheimer M. Temporary threshold shift due to noise exposure in guinea pigs under emotional stress. Hear. Res. 58 (1992) 101-106
67. Musiek F.E., and Baran J.A. Canal electrode electrocochleography in patients with absent wave I ABRs. Otolaryngol. Head Neck Surg. 103 (1990) 25-31
68. Niedzielski A.S., Safieddine S., and Wenthold R.J. Molecular analysis of excitatory amino acid receptor expression in the cochlea. Audiol. Neur.-Otol. 2 (1997) 79-91
69. Nordang L., Oestreicher E., Arnold W., and Anniko M. Glutamate is the afferent neurotransmitter in the human cochlea. Acta Otolaryngol. 120 (2000) 359-362
70. North R.A. Opioid receptor types and membrane ion channels. Trends Neurosci. 9 (1986) 114-117
71. Nowak L., Bregestovski P., Ascher P., Herbet A., and Prochaintz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307 (1984) 462-465
72. Oestreicher E., Arnold W., and Felix D. Neurotransmission of the cochlear inner hair cell synapse-implications for inner ear therapy. Adv. Oto-Rhino-Laryngol. 59 (2002) 131-139
73. Ohlsén K.A., Didier A., Baldwin D., Miller J.M., Nuttall A.L., and Hultcrantz E. Cochlear blood flow in response to dilating agents. Hear. Res. 58 (1992) 19-25
74. Ohlsén K.A., Hultcrantz E., and Engström B. The effect of topical application of vasodilating agents on cochlear electrophysiology. Acta Otolaryngol. 113 (1993) 55-61
75. Puel J.L. Chemical synaptic transmission in the cochlea. Prog. Neurobiol. 47 (1995) 449-476
76. Puel J.-L., Ladrech S., Chabert R., Pujol R., and Eybalin M. Electrophysiological evidence for the presence of NMDA receptors in the guinea pig cochlea. Hear. Res. 51 (1991) 255-264
77. Puel J.-L., d'Aldin C., Ruel J., Ladrech S., and Pujol R. Synaptic repair mechanisms responsible for functional recovery in various cochlear pathologies. Acta Otolaryngol. 117 (1997) 214-218
78. Puel J.-L., Ruel J., Guitton M., and Pujol R. The inner hair cell afferent/efferent synapses revisited: a basis for new therapeutic strategies. In: Felix D., and Oestreicher E. (Eds). Adv. Otolaryngol. vol. 59 (2002) 124-130
79. Puel J.-L., Ruel J., Guitton M., and Pujol R. The inner hair cell synaptic complex: physiology, pharmacology and new therapeutic strategies. Audiol. Neurootol. 7 (2002) 49-54
80. Pujol R. Neural anatomy of the cochlea: development and plasticity. In: Jahn A.F., and Santos-Sacchi J. (Eds). Physiology of The Ear. second ed. (2001), Singular-Thomson Learning, San Diego, CA 515-528
81. Pujol R., Puel J.-L., and Eybalin M. Implication of non-NMDA and NMDA receptors in cochlear ischemia. Neuroreport 3 (1992) 299-302
82. Pujol R., Puel J.-L., Gervais-d'Aldin C., and Eybalin M. Pathophysiology of the glutamate synapses in the cochlea. Acta Otolaryngol. 113 (1993) 330-334
83. Safieddine S., and Eybalin M. Co-expression of NMDA and AMPA/kainate receptor mRNAs in cochlear neurones. Neuroreport 3 (1992) 1145-1148
84. Safieddine S., Prior A.M.S., and Eybalin M. Choline acetyltransferase, glutamate decarboxylase, tyrosine hydroxylase, calcitonin gene-related peptide and opioid peptides coexist in lateral efferent neurons of rat and guinea-pig. Eur. J. Neurosci. 9 (1997) 356-367
85. Sahley T.L., and Nodar R.H. Improvement in auditory function following pentazocine suggests a role for dynorphins in auditory sensitivity. Ear Hear. 15 (1994) 422-431
86. Sahley T.L., and Nodar R.H. A biochemical model of peripheral tinnitus. Hear. Res. 152 (2001) 43-54
87. Sahley T.L., and Nodar R.H. In: Donald P.J., and Gluckman J.L. (Eds). Please check taggings: Tinnitus: Present and Future. Current opinion: Otolaryngol. Head Neck Surg. vol. 9 (2001) 323-328
88. Sahley T.L., Kalish R.B., Musiek F.E., and Hoffman D.W. Effects of opioid drugs on auditory evoked potentials suggest a role of lateral olivocochlear dynorphins in auditory function. Hear. Res. 55 (1991) 133-142
89. Sahley T.L., Chernicky C.L., Nodar R.H., and Musiek F.E. Pro-dynorphin peptides are co-localized within auditory structures of the chinchilla brainstem. Abs. Assoc. Res. Otolaryngol.. 18 (1995) 170
90. Sahley T.L., Musiek F.E., and Nodar R.H. Naloxone blockade of (-)-pentazocine-induced changes in auditory function. Ear Hear. 17 (1996) 341-353
91. Sahley T.L., Nodar R.H., and Musiek F.E. Blockade of opioid-induced changes in auditory function at the level of the cochlea. Ear Hear. 17 (1996) 552-558
92. Sahley T.L., Nodar R.H., and Musiek F.E. Efferent Auditory System: Structure and Function (1997), Singular Publishing, San Diego, CA
93. Sahley T.L., Nodar R.H., and Musiek F.E. Endogenous dynorphins: possible role in peripheral tinnitus. Int. Tinnitus J. 5 (1999) 76-91
94. Samra S.K., Lilly D.J., Rush N.L., and Kirsh M.M. Fentanyl anesthesia and human brain-stem auditory evoked potentials. Anesthesiology 61 (1984) 261-265
95. Samra S.K., Krutak-Krol H., Pohorecki R., and Domino E.F. Scopolamine, morphine, and brain-stem auditory evoked potentials in awake monkeys. Anesthesiology 62 (1985) 437-441
96. Searchfield G.D., Muñoz D.J.B., and Thorne P.R. Ensemble spontaneous activity in the guinea-pig cochlear nerve. Hear. Res. 192 (2004) 23-35
97. Sewell W.F. Neurotransmitters and synaptic transmission. In: Dallos P., Popper A.N., and Fay R.R. (Eds). The Cochlea (1996), Springer Verlag, New York, N.Y. 503-533
98. Shukla V.K., and Lemaire S. Non-opioid effects of dynorphins: possible role of the NMDA receptor. Trends Pharmacol. Sci. 15 (1994) 420-424
99. Simmons D.D. Development of the inner ear efferent system across vertebrate species. J. Neurobiol. 53 (2002) 228-250
100. Skilling S.R., Sun X., Kurtz H.J., and Larson A.A. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity. Brain Res. 575 (1992) 272-278
101. Smith D.I., and Mills J.H. Anesthesia effects: auditory brain-stem response. Electroencephalogr. Clin. Neurophysiol. 72 (1989) 422-428
102. Spagnoli S.D., and Saunders J.C. Threshold sensitivity and frequency selectivity measured with round window whole nerve action potentials in the awake, restrained chinchilla. Otolaryngol. Head Neck Surg. 96 (1987) 99-105
103. Stein C. Nociceptors and neuroimmune interactions. In: Belmonte C., and Cervero F. (Eds). Neurobiology of Nociceptors (1996), Oxford University Press, New York, N.Y. 439-452
104. Stricker N.L., and Huganir R.L. AMPA/kainate receptors. In: Moss S.J., and Henley J. (Eds). Receptor and Ion-Channel Trafficking: cell biology of ligand-gated and voltage-sensitive ion channels (2002), Oxford University Press, New York, N.Y. 131-155
105. Suneja S.K., Benson C.G., Gross J., and Potashner S.J. Uptake and release of d-aspartate, GABA and glycine in guinea pig brainstem auditory nuclei. J. Neurochem. 64 (1995) 147-160
106. Suneja S.K., Benson C.G., Gross J., and Potashner S.J. Evidence for glutamatergic projections from the cochlear nucleus to the superior olive and ventral nucleus of the lateral lemniscus. J. Neurochem. 64 (1995) 161-171
107. 3H]-ethylketocyclazocine, m, k, ä and phencyclidine binding sites in guinea pig brain membranes. Eur. J. Pharmacol. 109 (1985) 33-41
108. Tang Q., Gandhoke R., Burritt A., Hruby V.J., Porreca F., and Lai J. High-affinity interaction of [des-Tyrosyl) dynorphin A (2-17) with NMDA receptors. J. Pharmacol. Exp. Ther. 291 (1999) 760-765
109. Trautwein P., Hofstetter P., Wang J., Salvi R., and Nostrant A. Selective inner hair cell loss does not alter distortion product otoacoustic emissions. Hear. Res. 96 (1996) 71-82
110. Usami S., Matsubara A., Fujita S., Takumi Y., and Otterson O.P. Glutamate neurotransmission in the mammalian inner ear. In: Ottersen O.P., and Storm-Mathison J. (Eds). glutamate. Handbook of Chemical Anatomy vol. 18 (2000), Elsevier Publishers, New York, N.Y. 225-271
111. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., Malan T.P., and Porreca F. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long lasting allodynia in rats: blockade by MK-801 but not by naloxone. Pain 68 (1996) 275-281
112. Von Voigtlander P.F., Lahti R.A., and Ludens J.H. U-50488: a selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224 (1983) 7-12
113. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., de Costa B., and Rice K.C. Sigma receptors: biology and function. Pharmacol. Rev. 42 (1990) 355-402
114. Walsh E.J., McGee J., McFadden S.L., and Liberman M.C. Long-term effects of sectioning the olivocochlear bundle in neonatal cats. J. Neurosci. 18 (1998) 3859-3869
115. Warr W.B. Organization of olivocochlear efferent systems in mammals. In: Webster D.B., Popper A.N., and Fay R.R. (Eds). The Mammalian Auditory Pathway: neuroanatomy (1992), Springer-Verlag, New York, N.Y. 410-448
116. Warr W.B., Boche J.B., and Neely S.T. Efferent innervation of the inner hair cell region: origins and terminations of two lateral olivocochlear systems. Hear. Res. 108 (1997) 89-111
117. Waxham M.N. Neurotransmitter receptors. In: Squire L.R., Bloom F.E., McConnell S.K., Roberts J.L., et al. (Eds). Fundamental Neuroscience. second ed. (2003), Academic Press, New York, N.Y. 225-258
118. Wisden W., Seeburg P.H., and Monyer H. AMPA, kainate and NMDA ionotropic glutamate receptor expression-an in situ hybridization atlas. In: Ottersen O.P., and Storm-Mathison J. (Eds). glutamate. Handbook of Chemical Anatomy vol. 18 (2000), Elsevier Publishers, New York, N.Y. 99-143
119. Zhang L., Peoples R.W., Oz M., Harvey-White J., Weight F.F., and Brauneis U. Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations. J. Neurophysiol. 78 (1997) 582-590
120. Zukin R.S., and Zukin S.R. The case for multiple opiate receptors. Trends Neurosci. 7 (1984) 160-164